Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cystic Fibrosis
100%
Cystic Fibrosis Foundation
44%
Diabetes
42%
Consensus Statement
28%
Lung Transplantation
28%
Weight Gain
21%
Hypoglycemia
19%
Obesity
16%
Endocrinology
16%
Cardiometabolic Risk
15%
Energy Balance
14%
Cystic Fibrosis-related Diabetes
14%
Male Reproductive Health
14%
Adult Patients
14%
Severe Hypoglycemia
14%
Weight Parameter
14%
Hypoglycemia Unawareness
14%
Nutritional Considerations
14%
Emerging Treatments
14%
Metabolic Parameters
14%
Ventricular Arrhythmia
14%
Lung Function
14%
Counterregulation
14%
Forced Expiratory Volume in 1 Second (FEV1)
14%
Elexacaftor-tezacaftor-ivacaftor
14%
Recurrent Hypoglycemia
14%
Position Paper
14%
Repeated Testing
14%
Clostridium Difficile Infection
14%
Test Sensitivity
14%
Pseudo-outbreak
14%
Perceived Prevalence
14%
Overweight/obesity
14%
Liver-kidney
14%
High Risk
14%
Pernicious Anemia
14%
Gastric Pathology
14%
Lipid-lowering Therapy
14%
Autoimmune Disease
14%
Chronic Kidney Disease
14%
Comorbidity
8%
Cardiometabolic
8%
Insulin Deficiency
7%
Insulin Resistance
7%
BMI Classification
7%
Body Mass Index
6%
Glycemic Control
6%
Toxin Assays
6%
Esophagogastroduodenoscopy
6%
Stomach Lesions
6%
Medicine and Dentistry
Cystic Fibrosis
78%
Diabetes
42%
Lung Transplantation
28%
Hypoglycemia
28%
Male Reproductive Health
14%
Energy Balance
14%
Pernicious Anemia
14%
Autoimmune Disease
14%
Chronic Kidney Disease
14%
Lipid
14%
Arrhythmia
14%
Severe Hypoglycemia
14%
Emerging Treatment
14%
Patient with Cystic Fibrosis
9%
Resting Energy Expenditure
9%
Endocrinology
9%
Statin
8%
Insulin
7%
Comorbidity
7%
Insulin Deficiency
7%
Nephropathy
6%
Stomach Lesion
6%
Esophagogastroduodenoscopy
6%
Nutrition
5%